Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Short term Debt (2016 - 2025)

Historic Short term Debt for Ultralife (ULBI) over the last 10 years, with Q3 2025 value amounting to $3.8 million.

  • Ultralife's Short term Debt rose 8905.0% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 8905.0%. This contributed to the annual value of $2.8 million for FY2024, which is 3750.0% up from last year.
  • Latest data reveals that Ultralife reported Short term Debt of $3.8 million as of Q3 2025, which was up 8905.0% from $3.4 million recorded in Q2 2025.
  • In the past 5 years, Ultralife's Short term Debt ranged from a high of $3.8 million in Q3 2025 and a low of $253000.0 during Q3 2021
  • Over the past 4 years, Ultralife's median Short term Debt value was $2.0 million (recorded in 2023), while the average stood at $2.1 million.
  • Per our database at Business Quant, Ultralife's Short term Debt plummeted by 8353.94% in 2021 and then surged by 8905.0% in 2025.
  • Quarter analysis of 4 years shows Ultralife's Short term Debt stood at $253000.0 in 2021, then soared by 690.51% to $2.0 million in 2023, then surged by 37.5% to $2.8 million in 2024, then skyrocketed by 37.49% to $3.8 million in 2025.
  • Its Short term Debt was $3.8 million in Q3 2025, compared to $3.4 million in Q2 2025 and $3.1 million in Q1 2025.